In today's Pharmaceutical Executive Daily, Novartis agrees to acquire Excellergy for up to $2 billion to advance a ...

While they may be linked, the administration’s DTC drug coupon site is not necessarily the entirety of its MFN efforts. With ...

Yerem Yeghiazarians, MD, discusses the importance of understanding why certain cells (like cancer cells) can survive in situations that would kill other healthy cells.

Learn how CareTria's integrated, automated platform streamlines therapy initiation and increases patient conversion rates.

Kresladi becomes the first FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2, and ...

The White House postponed naming a permanent CDC director as the Trump administration navigates competing political pressures ...

When you talk about pharmaceuticals specifically, and any movement involving either equipment or drugs or patient samples, ...

Icotyde is the first targeted oral peptide IL‑23 receptor antagonist, designed to interrupt a core psoriasis inflammatory axis while avoiding injection-based administration typical of IL‑23 biologics.

In today's Pharmaceutical Executive Daily, the Trump administration misses a statutory deadline to nominate a permanent CDC ...

FDA accelerated approval positions Avlayah as the first therapy engineered to cross the blood–brain barrier for MPS ...

For pharma products, ensuring proper delivery requires the majority of work to occur before the product hits the road.

War in the Middle East disrupts pharmaceutical supply chains in the Gulf region, forcing drugmakers to reroute shipments of ...